These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6126204)

  • 1. Beta-blockade after myocardial infarction--a statistical view.
    Lewis JA
    Br J Clin Pharmacol; 1982; 14 Suppl 1(Suppl 1):15S-21S. PubMed ID: 6126204
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-adrenergic blocking agents after myocardial infarction: an undocumented need in patients at lowest risk.
    Griggs TR; Wagner GS; Gettes LS
    J Am Coll Cardiol; 1983 Jun; 1(6):1530-3. PubMed ID: 6133891
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter: Beta-blockade and myocardial infarction.
    Fox KM; Chopra MP; Portal RW; Aber CP
    Br Med J; 1975 Apr; 2(5964):193-4. PubMed ID: 236072
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta-adrenergic blockade for survivors of acute myocardial infarction.
    N Engl J Med; 1984 Sep; 311(10):670-1. PubMed ID: 6147752
    [No Abstract]   [Full Text] [Related]  

  • 5. [Beta blockade after myocardial infarction or not?].
    Hjalmarson A
    Lakartidningen; 1988 Oct; 85(41):3368-9. PubMed ID: 2905020
    [No Abstract]   [Full Text] [Related]  

  • 6. Saving lives after myocardial infarction: the role of beta-adrenergic blockers.
    Frishman WH
    Mt Sinai J Med; 1990 Mar; 57(2):75-84. PubMed ID: 1973260
    [No Abstract]   [Full Text] [Related]  

  • 7. [Secondary prevention of myocardial infarct using beta-blockers].
    Vacheron A
    Bull Acad Natl Med; 1985 Mar; 169(3):369-73. PubMed ID: 2864119
    [No Abstract]   [Full Text] [Related]  

  • 8. From the NIH: Implications of the recent beta-blocker clinical trials for patients after myocardial infarction.
    JAMA; 1983 May; 249(18):2482-3. PubMed ID: 6133013
    [No Abstract]   [Full Text] [Related]  

  • 9. [Adrenergic beta receptor blockaders as a secondary prevention after acute myocardial infarction].
    Jensen G; Sigurd B
    Ugeskr Laeger; 1981 Nov; 143(48):3241-5. PubMed ID: 6120594
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of pharmacotherapy in secondary prevention of myocardial infarction and death.
    Gorlin R; Fuster V
    Mt Sinai J Med; 1984 Jun; 51(3):229-36. PubMed ID: 6146929
    [No Abstract]   [Full Text] [Related]  

  • 11. Now you see it, now you don't. Eccentricities and anomalies in the results of beta-blocking trials.
    Hampton JR
    Br J Clin Pharmacol; 1982; 14 Suppl 1(Suppl 1):51S-55S. PubMed ID: 6126209
    [No Abstract]   [Full Text] [Related]  

  • 12. Prophylactic use of beta-adrenergic blockade in survivors of myocardial infarction.
    Rotmensch HH; Vlasses PH; Ferguson RK
    Heart Lung; 1984 Jul; 13(4):366-71. PubMed ID: 6145686
    [No Abstract]   [Full Text] [Related]  

  • 13. [Value of beta-blockers in the long-term prevention of morbidity and mortality after myocardial infarction].
    Haïat R; Desoutter P
    Coeur Med Interne; 1980; 19(1):61-5. PubMed ID: 6103776
    [No Abstract]   [Full Text] [Related]  

  • 14. Should every survivor of a heart attack be given a beta-blocker? Part III. Some conclusions.
    Rose G
    Br Med J (Clin Res Ed); 1982 Jul; 285(6334):39-40. PubMed ID: 6123367
    [No Abstract]   [Full Text] [Related]  

  • 15. Audit of secondary prophylaxis after myocardial infarction.
    Whitford DL; Southern AJ
    BMJ; 1994 Nov; 309(6964):1268-9. PubMed ID: 7888849
    [No Abstract]   [Full Text] [Related]  

  • 16. Beta-blockade for patients undergoing vascular surgery.
    Feldman T; Fusman B; McKinsey JF
    N Engl J Med; 2000 Apr; 342(14):1051-2; author reply 1052-3. PubMed ID: 10755896
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta-blockers in the prevention of myocardial infarction.
    Hampton JR
    Practitioner; 1984 Jan; 228(1387):55-63. PubMed ID: 6141556
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta-blockers in the treatment of myocardial infarction.
    Baber NS; Lewis JA
    Br Med J; 1980 Jul; 281(6232):59. PubMed ID: 6105898
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic progress--Review III. Can drugs prevent recurrent myocardial infarction?
    Burley DM
    J Clin Hosp Pharm; 1982 Mar; 7(1):1-15. PubMed ID: 6124554
    [No Abstract]   [Full Text] [Related]  

  • 20. [Secondary prevention following myocardial infarction--results of long-term studies].
    Berndt H
    Z Arztl Fortbild (Jena); 1983; 77(2):52-8. PubMed ID: 6132502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.